Surgery confers survival benefit in De Novo metastatic soft tissue sarcoma patients with low Ki67 or low total lesion glycolysis: a combined PET/CT and clinicopathological analysis - Top-Institutions - MDSpire

Surgery confers survival benefit in De Novo metastatic soft tissue sarcoma patients with low Ki67 or low total lesion glycolysis: a combined PET/CT and clinicopathological analysis

  • By

  • Shaoli Li

  • Xin Zheng

  • Menglei Jin

  • Hui Wang

  • Rui Bai

  • Ying Dong

  • July 10, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Second Affiliated Hospital, Zhejiang University School of Medicine
    Second Affiliated Hospital, Zhejiang University School of Medicine

    Hangzhou, Zhejiang

    Key Differentiators

    • Surgical Oncology

  • #2

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Cancer Research

  • #3

    Society of Surgical Oncology
    Society of Surgical Oncology

    Phoenix, Arizona

    Key Differentiators

    • Surgical Oncology

Original Source(s)

Surgery confers survival benefit in De Novo metastatic soft tissue sarcoma patients with low Ki67 or low total lesion glycolysis: a combined PET/CT and clinicopathological analysis

  • by Shaoli Li, Xin Zheng, Menglei Jin, Hui Wang, Rui Bai, Ying Dong

  • July 10, 2026

Related Content

Efficacy and safety of neoadjuvant chemotherapy with immunotherapy versus chemotherapy alone in esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials

Macrophage reprogramming through scavenger receptor-guided and cathepsin B-triggered nanodelivery: from intracellular mechanisms to translational applications

Leptomeningeal disease (LMD) after resection of brain metastases: results of the multicenter SUBAROMA study